Ignite Creation Date:
2025-12-24 @ 9:55 PM
Ignite Modification Date:
2025-12-25 @ 7:33 PM
Study NCT ID:
NCT03964532
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-05-21
First Post:
2019-04-22
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
TALAVE: Induction Talazoparib Followed by Combination of Talazoparib and Avelumab in Advanced Breast Cancer
Sponsor:
Georgetown University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-04-17
Start Date Type:
ACTUAL
Primary Completion Date:
2026-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-03
Completion Date Type:
ESTIMATED
First Submit Date:
2019-04-22
First Submit QC Date:
None
Study First Post Date:
2019-05-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-20
Last Update Post Date:
2025-05-21
Last Update Post Date Type:
ACTUAL